(Q41066315)

26 September 2017

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma (English)

1 reference

26 September 2017

2

Takashi Kumada

1 reference

26 September 2017

4

Hidenori Toyoda

1 reference

26 September 2017

5

Toshifumi Tada

1 reference

26 September 2017

3

Kojiro Michitaka

1 reference

26 September 2017

1

Atsushi Hiraoka

1 reference

26 September 2017

20

Hideki Kawasaki

1 reference

26 September 2017

6

Hidetaro Ueki

1 reference

26 September 2017

8

Toshihiko Aibiki

1 reference

26 September 2017

9

Tomonari Okudaira

1 reference

26 September 2017

12

Hiroka Yamago

1 reference

26 September 2017

14

Yuji Miyamoto

1 reference

26 September 2017

15

Hideomi Tomida

1 reference

26 September 2017

17

Kenichiro Mori

1 reference

26 September 2017

18

Hideki Miyata

1 reference

26 September 2017

19

Tomoyuki Ninomiya

1 reference

26 September 2017

Miho Kaneto

7

1 reference

26 September 2017

Takamasa Kawakami

10

1 reference

26 September 2017

Tomoe Kawamura

11

1 reference

26 September 2017

Yoshifumi Suga

13

1 reference

26 September 2017

Nobuaki Azemoto

16

1 reference

26 September 2017

8 December 2015

1 reference

Journal of Gastroenterology and Hepatology

26 September 2017

1 reference

26 September 2017

31

1 reference

26 September 2017

5

1 reference

26 September 2017

1031-1036

1 reference

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

26 September 2017

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

21 January 2018

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

21 January 2018

1 reference

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

21 January 2018

1 reference

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis

21 January 2018

1 reference

Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan

21 January 2018

1 reference

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo

21 January 2018

1 reference

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis

21 January 2018

1 reference

Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan

21 January 2018

1 reference

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

21 January 2018

1 reference

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial

21 January 2018

1 reference

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

21 January 2018

1 reference

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

21 January 2018

1 reference

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

21 January 2018

1 reference

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13250

1 reference

26 September 2017

1 reference